Blair William & CO Bluebird Bio, Inc. Transaction History

Blair William & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$46.96 - $61.67 $109,228 - $143,444	-2,326 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$59.47 - $93.1 $6,541 - $10,241	-110 Reduced 4.52%	2,326 $214,000
Q2 2019 Aug 13, 2019	SELL	$75.84 - $105.21 $9,176 - $12,730	-121 Reduced 4.73%	2,436 $310,000
Q1 2019 May 14, 2019	BUY	$64.44 - $104.11 $32,864 - $53,096	510 Added 24.91%	2,557 $402,000
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $10,933 - $17,253	185 Added 9.94%	2,047 $203,000
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $165,457 - $218,766	1,862 New	1,862 $272,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.